Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma. The gene discussed is PPP1R9A; the disease is primary central nervous system lymphoma.